When people start researching prohormones, 3-AD tends to come up quickly. It’s frequently described as one of the cleaner options in the category: no estrogen conversion, no water retention, lean dry gains.
That pitch is appealing, especially compared to the bloating and hormonal volatility associated with older prohormone compounds.
But the full picture is more nuanced than that. 3-AD, which refers to androstenediol and its derivatives, has a documented research base, a genuine anabolic mechanism, and real results reported by users.
Unfortunately, it also comes with meaningful risks, a significant legal restriction, and a side effect profile that deserves honest discussion rather than a footnote.
This guide covers all of it. What 3-AD actually is, how it works in the body, what the research shows about its effects, realistic dosage ranges, what to expect from a cycle, how to manage it properly, and who should probably leave it alone.
Key Insights 💡
- 3-AD (androstenediol) is a prohormone that converts to testosterone in the body via enzymatic conversion, making it an indirect androgen precursor rather than a direct anabolic steroid. 🔬
- Unlike many prohormones, 3-AD has a low rate of conversion to estrogen, which means less risk of water retention and gynecomastia compared to androstenedione and certain other precursors. 💪
- Clinical research on androstenediol prohormones shows real but modest testosterone elevations at doses of 200 mg or more, with performance and body composition benefits most pronounced in structured resistance training contexts. 📋
- Lipid panel changes, specifically reductions in HDL cholesterol, are the most consistently documented adverse effect across the prohormone research literature and should be monitored with bloodwork. ⚠️
- 3-AD is a Schedule III controlled substance in the US and is banned by WADA and the NCAA. Post-cycle therapy (PCT) is required after any cycle to restore natural testosterone production. ✅
What Is 3-AD?
3-AD refers to androstenediol, specifically 5-androstenediol (5-AD). Alternatively it could also be a reference to its structural variants, which function as prohormones in the body.
A prohormone is not an active hormone itself. It’s a precursor compound that your body’s enzymes convert into an active hormone after ingestion. In the case of 3-AD, the downstream conversion target is testosterone.
Androstenediol is produced naturally in small amounts by the adrenal glands and gonads as part of the normal steroidogenic pathway. The synthetic versions used in prohormone supplements are structurally identical or closely related to this endogenous compound, which is part of why they were initially marketed as natural testosterone support products rather than anabolic steroids.
That framing did not last. Under the Anabolic Steroid Control Act of 2004, androstenediol and its derivatives were classified as Schedule III controlled substances in the United States, placing them in the same legal category as anabolic steroids. They are banned by WADA and the NCAA, and possession without a prescription is illegal in the US.
The modern supplement market also sells products labeled 3-AD that use variants such as 3-beta-hydroxy-5-alpha-androst-1-en-17-one, which converts to 1-testosterone rather than conventional testosterone.
These compounds have a somewhat different profile and are discussed in their own right in some research, but the underlying prohormone mechanism is the same: an inactive precursor is converted to an active androgen through normal enzymatic activity in peripheral tissue.
How Does 3-AD Work?
When you take 3-AD orally, it is absorbed through the gastrointestinal tract and enters circulation. In peripheral tissues, including skeletal muscle, it is converted to testosterone through the action of 17-beta-hydroxysteroid dehydrogenase (17-beta-HSD), the enzyme responsible for the final step in androgen biosynthesis.
Testosterone then binds to androgen receptors in muscle tissue, initiating the downstream cascade that drives muscle protein synthesis, nitrogen retention, and recovery.
The anabolic effects of 3-AD are therefore mediated through the same receptor-level pathway as testosterone itself, just with an additional enzymatic conversion step in between.
One important characteristic of androstenediol compared to androstenedione is its conversion profile.
Androstenedione converts relatively readily to estrogens via aromatase. Androstenediol’s primary conversion route goes toward testosterone rather than estrogen, which is why its estrogenic side effect profile is considered more manageable.
It does still carry some estrogenic activity through direct binding to estrogen receptors, but this is generally less pronounced than with androstenedione-based prohormones.
For the 1-testosterone-converting variants, the mechanism shifts slightly. 1-Testosterone does not aromatize to estrogen at all, making these compounds effectively dry androgens with no estrogenic conversion.
This is what drives the clean gains reputation associated with modern 3-AD formulations, and it is supported by both the pharmacological reasoning and user experience, though clinical data specifically on 1-testosterone conversion products is more limited than for traditional androstenediol.
3-AD Benefits: What the Research and User Data Show
The benefits attributed to 3-AD map closely onto the effects of elevated testosterone, because that is mechanistically what is being produced. Here is a breakdown of the primary areas, with the evidence behind each one.
Lean Muscle Mass
Increased muscle protein synthesis and improved nitrogen retention are the core anabolic mechanisms through which 3-AD supports lean mass gains. In studies on 1-androsterone, a closely related converting prohormone, researchers observed lean body mass increases of around 6.3% over just four weeks in resistance-trained men, compared to 0.5% in the placebo group.
These results were achieved alongside structured training, which is a consistent finding across the prohormone literature: the compounds amplify the training stimulus rather than producing results independently.
For 3-AD specifically, users typically report lean, dry mass gains without the puffiness associated with wet compounds, particularly when using non-aromatizing variants.
Strength Output
The same 1-androsterone study recorded back squat one-repetition maximum improvements of 14.3% in the prohormone group versus 5.7% in placebo over four weeks, with total powerlifting performance (bench, squat, deadlift combined) increasing by 12.8% versus 5.9% in controls.
Strength improvements are consistently reported in the user community for 3-AD cycles, with many noting that the strength increases become noticeable within the first two to three weeks of a cycle, often before visible mass changes become apparent.
Body Composition and Fat Loss
Elevated testosterone supports a more favorable body composition by increasing the ratio of lean mass to fat mass and supporting metabolic rate. In the controlled study referenced above, fat body mass decreased by 24.6% in the prohormone group versus 9.5% in placebo.
These are significant numbers, though the four-week duration and small sample size (nine subjects in the prohormone group) mean they should be interpreted with appropriate caution.
The anti-catabolic properties of androgen elevation also make 3-AD relevant during cutting phases, where preserving muscle mass under a caloric deficit is a primary concern.
Recovery and Training Capacity
Improved protein synthesis directly accelerates muscle repair between sessions, and elevated androgens reduce the catabolic impact of high-volume training.
Users on 3-AD cycles commonly report being able to train more frequently, recover faster between sessions, and sustain higher training intensities for longer without the same accumulation of fatigue.
Aggression and drive in training also tend to increase, which is a well-documented effect of elevated androgens and is reported across both clinical and user contexts.
No Estrogenic Side Effects (Non-Aromatizing Variants)
For variants that convert to 1-testosterone rather than conventional testosterone, the absence of aromatase conversion means no estrogen-related side effects. No water retention, no gynecomastia risk, no bloating.
This makes 3-AD non-aromatizing variants well-suited to cutting cycles where maintaining muscle dryness and definition is a priority, and is one of the primary reasons they have built a reputation as cleaner alternatives to older wet prohormones.
It is worth noting that traditional androstenediol variants still carry some estrogenic activity through direct receptor binding, so this advantage applies most clearly to the 1-testosterone-converting formulations.
3-AD Dosage and Cycle Guidelines
There is no clinically established dosing protocol for 3-AD in bodybuilding contexts. The ranges below are drawn from research literature on androstenediol prohormones and from documented user practice. They should be treated as reference points, not prescriptions.
Standard Male Dosage
For traditional androstenediol formulations, research used oral doses of 200 mg or more to observe meaningful testosterone elevation. In the bodybuilding community, doses of 100 to 150 mg per day are most commonly cited for beginners, with more experienced users ranging up to 200 to 300 mg per day.
Research suggests that doses below 300 mg per day over 12 weeks produced no significant changes in body composition or performance in some studies, which indicates that response is dose-dependent and that lower doses may not produce meaningful effects in all users.
For 1-testosterone-converting variants, which are more potent milligram for milligram, community-referenced doses tend to be lower, typically in the range of 100 to 200 mg per day, split across two to three doses throughout the day to maintain more consistent blood levels.
Cycle Length
Standard cycle lengths for 3-AD range from 8 to 12 weeks. Shorter cycles of 4 to 6 weeks are sometimes used by beginners to assess individual response and tolerance before committing to a longer run.
Cycles beyond 12 weeks are not recommended given the cumulative stress on the lipid panel and the hormonal suppression that increases with duration.
On-Cycle Support
Liver support is strongly recommended during any oral prohormone cycle. N-acetylcysteine (NAC) at 600 mg per day and milk thistle (silymarin) at 400 to 600 mg per day are the most commonly used support compounds.
TUDCA (tauroursodeoxycholic acid) at 250 to 500 mg per day is considered a stronger option for hepatoprotection and is worth considering for cycles longer than eight weeks.
Cardiovascular support, including regular monitoring of blood pressure and, ideally, bloodwork tracking lipids, is equally important given the consistent HDL reduction documented in prohormone research.
Post-Cycle Therapy (PCT)
PCT is not optional after a 3-AD cycle. Any compound that elevates testosterone beyond baseline will trigger negative feedback on the hypothalamic-pituitary-gonadal (HPG) axis, suppressing the body’s natural testosterone production.
Without PCT, testosterone can remain suppressed for weeks to months after the cycle ends, resulting in loss of gains, low energy, reduced libido, and mood disruption. A standard PCT protocol typically begins within 24 to 48 hours of the last dose and runs for four weeks.
Selective estrogen receptor modulators (SERMs) such as nolvadex (tamoxifen) or clomid (clomiphene) are the most commonly used PCT agents and should be obtained and planned in advance, not as an afterthought.
Side Effects and Health Risks: The Full Picture
This is the section that marketing materials tend to minimize, so it deserves direct treatment. The side effects associated with 3-AD and androstenediol prohormones in general are real, documented in clinical research, and relevant to anyone making an informed decision about using these compounds.
Lipid Panel Disruption
This is the most consistently documented adverse effect in the published literature. In the 1-androsterone study, HDL cholesterol dropped by 38.7% and LDL increased by 32.8% over just four weeks. The LDL-to-HDL ratio increased by 120% and the cholesterol-to-HDL ratio increased by 77.4%.
These are large, clinically meaningful changes in cardiovascular risk markers. The placebo group experienced none of these changes. Pre-cycle and post-cycle bloodwork tracking lipids is not a precaution, it is essential.
Liver Stress
The same study observed a 113.8% elevation in aspartate transaminase (AST), a liver enzyme, in the prohormone group. Oral prohormones are processed by the liver, and methylated variants carry a higher hepatotoxicity risk than non-methylated forms.
Liver support supplementation during the cycle and avoiding alcohol are standard practice for a reason. If pre-existing liver conditions are present, oral prohormone use is contraindicated.
Testosterone Suppression
Exogenous androgen elevation suppresses the HPG axis. The degree of suppression depends on dose and duration, but any meaningful cycle will result in some degree of natural testosterone suppression. Without proper PCT, post-cycle testosterone levels can remain depressed for extended periods, which is why PCT is a non-negotiable part of any prohormone cycle.
Androgenic Side Effects
As androgen levels rise, androgenic side effects become possible for individuals with genetic predisposition. Acne, increased body and facial hair, scalp hair loss acceleration, and prostate irritation are all in play. The severity varies significantly between individuals. People with a personal or family history of androgenic alopecia or prostate issues should weigh this carefully.
Kidney Markers and Serum Albumin
The 1-androsterone research also noted elevations in serum creatinine (19.6%), reductions in glomerular filtration rate (18%), and reductions in serum albumin (5.1%) in the prohormone group. These kidney function markers are less commonly discussed than liver and lipid effects but reinforce the importance of bloodwork monitoring throughout any cycle. Staying well hydrated and avoiding additional nephrotoxic compounds during a cycle is advisable.
Who Should and Should Not Consider 3-AD
3-AD is not a beginner compound, and it is not suitable for everyone. Being direct about this is more useful than hedging.
Anyone who has not first maximized their results from training, nutrition, and recovery has no practical reason to take on the risks of a prohormone cycle. Natural testosterone production in a well-trained, well-fed, well-rested athlete is capable of driving substantial progress. A prohormone adds hormonal stress and legal/health risk on top of a foundation that most people have not yet built.
3-AD is also not appropriate for anyone under 21, since the endocrine system is still developing through early adulthood and external androgen input can disrupt this process in ways that are difficult to reverse.
It should not be used by women outside of closely monitored clinical contexts due to virilization risk. Anyone with pre-existing cardiovascular disease, liver conditions, kidney dysfunction, or a history of hormone-sensitive conditions should not use prohormones.
For experienced, health-screened, adult male athletes who understand the full risk profile, have planned their cycle and PCT properly, and are committed to monitoring bloodwork before, during, and after their cycle, 3-AD represents one of the more manageable options in the prohormone category. That is a specific and narrow population, not a general recommendation.
Legal Status and What to Know Before Buying
In the United States, androstenediol and its derivatives are Schedule III controlled substances under the Anabolic Steroid Control Act of 2004.
This means possession without a prescription is a federal offense. They are not available as over-the-counter dietary supplements in the US, despite some products continuing to be sold in grey market contexts.
Internationally, the legal status varies. In many countries, these compounds sit in an unregulated grey area where they are not explicitly scheduled but also not approved for sale as medicines or supplements.
Athletes competing under WADA, USADA, the NCAA, or most professional sports bodies should note that all androstenediol-derived prohormones are on the banned substance list, and detection windows extend well beyond the cycle itself.
For anyone purchasing these compounds regardless of jurisdiction, sourcing from suppliers with published third-party certificates of analysis is the most important quality control available.
Given that these products are not regulated as pharmaceuticals, label accuracy and contamination risk are legitimate concerns that third-party testing is the best practical defense against.
Conclusion
3-AD occupies a specific and well-defined place in the prohormone landscape. It is not the riskiest compound in the category, but it is also not as clean or consequence-free as some of its marketing suggests.
The research on androstenediol prohormones is consistent enough to confirm real effects on muscle mass and strength in the context of structured training. It is equally consistent in documenting the lipid, liver, and kidney changes that come with those effects.
What separates a responsible 3-AD cycle from a reckless one is the preparation: pre-cycle bloodwork, proper on-cycle support, a planned PCT, and post-cycle bloodwork to confirm recovery. These are not optional extras. They are the difference between using the compound intelligently and simply hoping for the best.
For the right person, in the right context, with the right preparation, 3-AD has a legitimate track record. The honest version of this guide is that knowing all of the above before making that decision is exactly the point.
FAQ's
Frequently Asked Questions
Yes, without exception. Any prohormone that elevates androgens meaningfully will suppress the HPG axis and reduce natural testosterone production. A four-week PCT with a SERM such as tamoxifen or clomiphene is standard practice and should be planned before the cycle starts, not sourced after it ends.
Some users do stack 3-AD with SARMs, typically to combine an anabolic stimulus with the targeted tissue selectivity of a SARM. However, stacking increases the hormonal suppression load and can compound side effects. Anyone new to either class of compound should run each individually before attempting a stack, and bloodwork monitoring becomes even more important in a combined protocol.
Most users report noticeable strength increases within the first two to three weeks of a cycle, with visible changes in muscle fullness and hardness following over weeks three to six. Body composition changes are most pronounced over the full eight to twelve weeks of a cycle in conjunction with consistent training and adequate protein intake.
In the United States, androstenediol and its derivatives are Schedule III controlled substances and are not legally available without a prescription. In other jurisdictions the status varies. Competitive athletes should assume any androstenediol-derived prohormone is on their governing body’s banned substance list and plan accordingly.
4-AD (4-androstenediol) converts to conventional testosterone and aromatizes, meaning it carries estrogenic side effect risk including water retention and gynecomastia.
3-AD, particularly in its 1-testosterone-converting form, does not aromatize, making it a drier compound with less estrogenic activity. The tradeoff is that some users find the gains from non-aromatizing prohormones less dramatic than from compounds that produce conventional testosterone, which has broader anabolic effects through both androgenic and estrogenic receptor pathways.
DISCLAIMER: The information provided in this article is for educational and informational purposes only. 3-AD and androstenediol derivatives are Schedule III controlled substances in the United States and are banned by WADA and the NCAA. This content does not constitute medical or legal advice. Always consult a qualified healthcare professional before using any hormonal compound.
more insights
